Glucocorticoid Receptor Signaling in NSCLC: Mechanistic Aspects and Therapeutic Perspectives

Recent advances in non-small cell lung cancer (NSCLC) biology and the discovery of novel therapeutic targets have led to the development of new pharmacological agents that may improve the clinical outcome of patients with NSCLC. The glucocorticoid receptor (GR) is an evolutionarily conserved protein...

Descripción completa

Detalles Bibliográficos
Autores principales: Papavassiliou, Kostas A., Anagnostopoulos, Nektarios, Papavassiliou, Athanasios G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526876/
https://www.ncbi.nlm.nih.gov/pubmed/37759686
http://dx.doi.org/10.3390/biom13091286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526876/
https://www.ncbi.nlm.nih.gov/pubmed/37759686
http://dx.doi.org/10.3390/biom13091286

Ejemplares similares